Surfaxin
Active Ingredient(s): LucinactantFDA Approved: * March 6, 2012
Pharm Company: * DISCOVERY LABORATORIES INC
Category: Respiratory Failure
Lucinactant (trade name Surfaxin) is a liquid medication used to treat infant respiratory distress syndrome.[1] It is a pulmonary surfactant for infants who lack enough natural surfactant in their lungs. Whereas earlier medicines of the class, such as beractant (Survanta & Beraksurf), calfactant (Infasurf), and poractant (Curosurf), are derived from animals, lucinactant is synthetic. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.